Completed PHASE4 INTERVENTIONAL 2-arm NCT03019198

TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL

Sponsor: Instituto Nacional de Traumatologia e Ortopedia

Conditions Blood Loss, Surgical Hip Replacement Tranexamic Acid Adverse Reaction

Interventions Placebo - Concentrate Tranexamic Acid Injectable Solution

Updated 6 times since 2017 Last updated: Mar 7, 2017 Started: Dec 31, 2013 Primary completion: Mar 31, 2014 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Blood Loss, Surgical and Hip Replacement, this trial is completed. The trial is conducted by Instituto Nacional de Traumatologia e Ortopedia and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Apr 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Feb 2017 — Apr 2017 [monthly]

Completed PHASE4

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Traumatologia e Ortopedia

Data source: Instituto Nacional de Traumatologia e Ortopedia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rio de Janeiro, Brazil